平衡晶体液与生理盐水用于重症患者(BEST-Living):系统评价与个体患者数据荟萃分析
该研究为系统评价与个体患者数据荟萃分析,纳入6项随机对照试验共34685例ICU成人患者(平衡晶体液组17407例,生理盐水组17278例),比较平衡溶液与生理盐水对院内死亡的影响。结果显示,平衡晶体液组院内死亡2907/17313(16.8%),生理盐水组2975/17166(17.3%),OR 0.962(95% CrI 0.909–1.019),绝对差-0.4个百分点(-1.5至0.2),平衡溶液降低死亡的后验概率为0.895。在创伤性脑损伤亚组中,平衡晶体液组死亡191/999(19.1%),生理盐水组141/962(14.7%),OR 1.424(1.100–1.818),绝对差3.2个百分点(0.7至8.7),平衡溶液增加死亡的概率为0.975。作者结论认为,平衡溶液降低院内死亡的概率高,但证据确定性中等且绝对风险降低小;在创伤性脑损伤患者中,使用平衡溶液与院内死亡增加相关。
要点
- 在ICU成人中,平衡晶体液组院内死亡2907/17313(16.8%),生理盐水组2975/17166(17.3%),OR 0.962(95% CrI 0.909–1.019),绝对差-0.4个百分点(-1.5至0.2)。
- 平衡溶液降低院内死亡的后验概率为0.895,但证据确定性中等,绝对风险降低小。
- 创伤性脑损伤亚组中,平衡晶体液组死亡191/999(19.1%),生理盐水组141/962(14.7%),OR 1.424(1.100–1.818),绝对差3.2个百分点(0.7至8.7)。
- 创伤性脑损伤患者中平衡溶液增加死亡的概率为0.975,作者认为使用平衡溶液与院内死亡增加相关。
- 6项试验中2项偏倚风险低、4项偏倚风险高。
适用人群与场景
- 纳入标准:成人ICU患者,接受平衡溶液或生理盐水用于液体复苏和维持液,或仅用于维持液。
- 纳入试验为个体随机或整群随机对照试验,所分配液体在整个ICU住院期间使用,或以landmark死亡为主要终点的试验使用至死亡评估时间点(若≥28天)。
- 预设亚组包括创伤性脑损伤患者。
红旗征与不能漏的情况
- 创伤性脑损伤患者使用平衡溶液与院内死亡增加相关:平衡晶体液组死亡191/999(19.1%),生理盐水组141/962(14.7%),OR 1.424(1.100–1.818),绝对差3.2个百分点(0.7至8.7),平衡溶液增加死亡的概率为0.975。
研究设计与关键结果
- 研究类型:系统评价与个体患者数据荟萃分析;检索PubMed、Embase和CENTRAL数据库自建库至2022年3月1日(2023年9月1日更新),最终纳入6项随机对照试验。
- 样本量:共34685例参与者,平衡晶体液组17407例,生理盐水组17278例;平均年龄58.8岁(SD 17.5);34653例有可用数据者中女性14579例(42.1%),男性20074例(57.9%)。
- 主要终点(院内死亡):在同意报告院内死亡的患者中,平衡溶液组2907/17313(16.8%),生理盐水组2975/17166(17.3%),OR 0.962(95% CrI 0.909–1.019),绝对差-0.4个百分点(-1.5至0.2);平衡溶液降低死亡的后验概率为0.895。
- 创伤性脑损伤亚组:平衡溶液组死亡191/999(19.1%),生理盐水组141/962(14.7%),OR 1.424(95% CI 1.100–1.818),绝对差3.2个百分点(0.7至8.7);平衡溶液增加死亡的概率为0.975。
- 偏倚风险:独立评估中2项试验为低偏倚风险,4项为高偏倚风险。
证据类型、等级与局限
- 证据类型:系统评价与个体患者数据荟萃分析(纳入6项随机对照试验),采用贝叶斯回归模型。
- 证据确定性:中等。
- 局限:2项试验为低偏倚风险,4项为高偏倚风险;证据确定性中等;绝对风险降低小。
对床旁实践的改变
- 在ICU成人中,使用平衡溶液降低院内死亡的概率为0.895,但绝对风险降低小(-0.4个百分点,95% CrI -1.5至0.2),证据确定性中等。
- 在创伤性脑损伤患者中,使用平衡溶液与院内死亡增加相关(OR 1.424,95% CI 1.100–1.818),绝对差3.2个百分点(0.7至8.7)。
指南或共识出处
- BEST-Living系统评价与个体患者数据荟萃分析,发表于Lancet Respiratory Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The effect of balanced crystalloids compared with that of saline in critically ill patients overall and in specific subgroups is unclear. We aimed to assess whether use of balanced solutions, compared with 0·9% sodium chloride (saline), decreased in-hospital mortality in adult patients in intensive care units (ICUs).
METHODS: For this systematic review and individual patient data meta-analysis, we searched PubMed, Embase, and CENTRAL databases from inception until March 1, 2022 (updated Sept 1, 2023) for individually randomised and cluster-randomised trials comparing balanced solutions with saline for adult patients in the ICU. Eligible trials were those that allocated patients to receive balanced solutions or saline for fluid resuscitation and maintenance fluids, or for maintenance fluids only; and administered the allocated fluid throughout ICU admission or, for trials using landmark mortality as their primary outcome, until the timepoint at which mortality was assessed (if ≥28 days). Authors of eligible trials were contacted to request individual patient data. Data obtained from eligible trials were merged, checked for accuracy, and centrally analysed by use of Bayesian regression models. The primary outcome was in-hospital mortality. Prespecified subgroups included patients with traumatic brain injury. This study was registered with PROSPERO (CRD42022299282).
FINDINGS: Our search identified 5219 records, yielding six eligible randomised controlled trials. Data obtained for 34 685 participants from the six trials, 17 407 assigned to receive balanced crystalloids and 17 278 to receive saline, were included in the analysis. The mean age of participants was 58·8 years (SD 17·5). Of 34 653 participants with available data, 14 579 (42·1%) were female and 20 074 (57·9%) were male. Among patients who provided consent to report in-hospital mortality, 2907 (16·8%) of 17 313 assigned balanced solutions and 2975 (17·3%) of 17 166 assigned saline died in hospital (odds ratio [OR] 0·962 [95% CrI 0·909 to 1·019], absolute difference -0·4 percentage points [-1·5 to 0·2]). The posterior probability that balanced solutions reduced mortality was 0·895. In patients with traumatic brain injury, 191 (19·1%) of 999 assigned balanced and 141 (14·7%) of 962 assigned saline died (OR 1·424 [1·100 to 1·818], absolute difference 3·2 percentage points [0·7 to 8·7]). The probability that balanced solutions increased mortality in patients with traumatic brain injury was 0·975. In an independent risk of bias assessment, two trials were deemed to be at low risk of bias and four at high risk of bias.
INTERPRETATION: The probability that using balanced solutions in the ICU reduces in-hospital mortality is high, although the certainty of the evidence was moderate and the absolute risk reduction was small. In patients with traumatic brain injury, using balanced solutions was associated with increased in-hospital mortality.
FUNDING: HCor (Brazil) and The George Institute for Global Health (Australia).
参考来源
- Zampieri FG, Cavalcanti AB, Di Tanna GL, et al. Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis. Lancet Respir Med. 2023. PMID: 38043564. doi:10.1016/S2213-2600(23)00417-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。